
Journal of labelled compounds and radiopharmaceuticals p. 385 - 394 (2000)
Update date:2022-07-30
Topics:
Katsifis, Andrew
Mattner, Filomena
Zhang, Zhianko
Dikic, Branko
Papazian, Vahan
The [123I] labelled imidazo[1,2-a]pyridine [123I]iodozolpidem 4 was found to exhibit preferential activity towards Peripheral rather than Central Benzodiazepine receptors in vivo and was synthesised for the potential study of the Peripheral Benzodiazepine Receptors (PBR) using SPECT. [123I]Iodozolpidem was prepared from the corresponding tributyl tin precursor by iododestannylation with Na[123I] in the presence of peracetic acid or chloramine-T. Purification by semipreparative C-18 RP HPLC gave the product in radiochemical yields of 60-85%. The product was obtained in > 97% chemical and radiochemical puritiy with a specific activity > 80 GBq/μmol.
View MoreBeijing Cooperate Pharmaceutical Co.,Ltd
website:http://www.cooperate-pharm.com/
Contact:86-01060279497
Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
Cangzhou Senary Chemical Science-tech Co., Ltd
Contact:+86-317-3563899, 3563699
Address:168 Jinde Road, Cangzhou, Hebei, China
Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd
Contact:86-27-52341789
Address:Room 1518 B suite, optical valley time square, No 111 Guanshan Road, Hongshan District,Wuhan,Hubei Province,China.
Springchem New Material Technology Co.,Limited
website:http://www.spring-chem.com
Contact:86-21-62885108
Address:602B, Building 1, No. 641, Tianshan Road
Contact:+86-515-88356562
Address:No.2, West Daqing Road, Yancheng, Jiangsu, China
Doi:10.1021/jm00298a049
(1970)Doi:10.1021/ol025760o
(2002)Doi:10.1016/S0040-4020(00)00193-9
(2000)Doi:10.1021/acs.joc.6b01286
(2016)Doi:10.1016/S0040-0(02)01564-8
(2003)Doi:10.1063/1.1286418
(1943)